Viet Thang Corp
VN:TVT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Viet Thang Corp
VN:TVT
|
VN |
|
Vitrolife AB
STO:VITR
|
SE |
|
Antigenics Inc
OTC:ANTI
|
US |
|
Gaxos.AI Inc
NASDAQ:GXAI
|
US |
|
X
|
Xebra Brands Ltd
CNSX:XBRA
|
CA |
|
V
|
Vikas Lifecare Ltd
BSE:542655
|
IN |
|
Bridgestone Corp
TSE:5108
|
JP |
|
T
|
Tien Len Steel Corporation JSC
VN:TLH
|
VN |
|
P
|
Pangenomic Health Inc
CNSX:NARA
|
CA |
Balance Sheet
Balance Sheet Decomposition
Viet Thang Corp
Viet Thang Corp
Balance Sheet
Viet Thang Corp
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
116 565
|
46 131
|
170 919
|
70 633
|
72 141
|
153 803
|
222 146
|
105 905
|
270 070
|
156 363
|
197 056
|
333 069
|
|
| Cash |
73 565
|
46 131
|
74 419
|
40 005
|
60 141
|
78 803
|
136 146
|
85 905
|
264 979
|
155 363
|
197 056
|
303 069
|
|
| Cash Equivalents |
43 000
|
0
|
96 500
|
30 628
|
12 000
|
75 000
|
86 000
|
20 000
|
5 091
|
1 000
|
0
|
30 000
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
35 049
|
54 500
|
247 000
|
172 000
|
352 500
|
109 000
|
2 000
|
2 000
|
|
| Total Receivables |
339 274
|
320 091
|
358 517
|
358 779
|
329 714
|
359 156
|
288 625
|
290 159
|
255 828
|
211 662
|
201 018
|
238 574
|
|
| Accounts Receivables |
278 724
|
285 524
|
343 190
|
347 727
|
314 268
|
345 483
|
275 779
|
263 695
|
218 780
|
182 035
|
189 942
|
218 864
|
|
| Other Receivables |
60 550
|
34 567
|
15 327
|
11 052
|
15 446
|
13 673
|
12 846
|
26 464
|
37 048
|
29 627
|
11 076
|
19 711
|
|
| Inventory |
454 522
|
428 799
|
445 767
|
383 981
|
432 726
|
380 455
|
248 143
|
278 619
|
482 354
|
486 583
|
515 042
|
364 713
|
|
| Other Current Assets |
13 627
|
18 505
|
21 247
|
7 677
|
27 145
|
11 170
|
8 046
|
10 150
|
9 603
|
10 656
|
9 549
|
19 506
|
|
| Total Current Assets |
923 988
|
813 525
|
996 450
|
821 070
|
896 775
|
959 084
|
1 013 960
|
856 833
|
1 370 355
|
974 264
|
924 665
|
957 862
|
|
| PP&E Net |
784 023
|
781 851
|
715 297
|
653 054
|
632 533
|
562 036
|
488 610
|
439 801
|
370 771
|
406 816
|
329 872
|
279 232
|
|
| PP&E Gross |
784 023
|
781 851
|
715 297
|
653 054
|
632 533
|
562 036
|
488 610
|
439 801
|
370 771
|
406 816
|
329 872
|
279 232
|
|
| Accumulated Depreciation |
630 419
|
703 442
|
769 947
|
863 851
|
948 789
|
989 809
|
1 090 734
|
1 147 728
|
1 239 857
|
1 320 361
|
1 398 123
|
1 438 136
|
|
| Intangible Assets |
0
|
242
|
192
|
142
|
92
|
42
|
0
|
0
|
0
|
465
|
349
|
4 661
|
|
| Note Receivable |
292
|
267
|
245
|
335
|
265
|
19 365
|
19 355
|
19 240
|
240
|
100
|
110
|
110
|
|
| Long-Term Investments |
19 813
|
23 513
|
60 848
|
57 809
|
53 609
|
71 651
|
68 911
|
57 349
|
56 370
|
52 736
|
54 380
|
52 504
|
|
| Other Long-Term Assets |
11 750
|
15 592
|
14 785
|
24 888
|
21 824
|
19 017
|
23 166
|
17 565
|
15 544
|
21 918
|
26 093
|
7 842
|
|
| Total Assets |
1 739 865
N/A
|
1 634 989
-6%
|
1 787 817
+9%
|
1 557 299
-13%
|
1 605 098
+3%
|
1 631 195
+2%
|
1 614 002
-1%
|
1 390 788
-14%
|
1 813 280
+30%
|
1 456 300
-20%
|
1 335 469
-8%
|
1 302 211
-2%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
150 048
|
117 108
|
138 332
|
92 545
|
94 356
|
106 331
|
75 009
|
85 533
|
111 989
|
139 808
|
120 965
|
93 588
|
|
| Accrued Liabilities |
67 079
|
76 653
|
76 750
|
54 295
|
58 343
|
57 208
|
47 030
|
58 655
|
70 732
|
24 542
|
43 662
|
66 243
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
464 785
|
674 863
|
713 038
|
466 652
|
732 369
|
428 760
|
488 622
|
474 847
|
|
| Current Portion of Long-Term Debt |
639 568
|
584 658
|
693 122
|
583 054
|
59 127
|
32 656
|
22 053
|
18 203
|
18 635
|
34 384
|
23 253
|
16 741
|
|
| Other Current Liabilities |
72 407
|
60 249
|
75 077
|
18 313
|
99 029
|
95 751
|
100 222
|
65 177
|
201 319
|
148 624
|
34 156
|
38 581
|
|
| Total Current Liabilities |
929 101
|
838 667
|
983 282
|
748 206
|
775 639
|
966 809
|
957 352
|
694 220
|
1 135 044
|
776 119
|
710 659
|
689 999
|
|
| Long-Term Debt |
243 227
|
229 105
|
178 016
|
104 545
|
91 715
|
76 105
|
59 188
|
61 867
|
48 987
|
77 074
|
27 320
|
15 499
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
308
|
0
|
0
|
103
|
|
| Minority Interest |
72 393
|
68 427
|
71 242
|
73 824
|
74 091
|
68 861
|
67 819
|
64 742
|
62 028
|
61 330
|
57 865
|
53 151
|
|
| Other Liabilities |
210
|
240
|
1 701
|
1 651
|
1 651
|
2 536
|
4 871
|
5 256
|
6 945
|
27 241
|
31 691
|
19 125
|
|
| Total Liabilities |
1 244 932
N/A
|
1 136 439
-9%
|
1 234 241
+9%
|
928 226
-25%
|
943 097
+2%
|
1 114 311
+18%
|
1 089 230
-2%
|
826 085
-24%
|
1 253 313
+52%
|
941 764
-25%
|
827 535
-12%
|
777 878
-6%
|
|
| Equity | |||||||||||||
| Common Stock |
210 000
|
210 000
|
210 000
|
210 000
|
210 000
|
210 000
|
210 000
|
210 000
|
210 000
|
210 000
|
210 000
|
210 000
|
|
| Retained Earnings |
216 850
|
219 284
|
272 785
|
346 513
|
379 443
|
242 165
|
250 053
|
292 598
|
287 862
|
242 431
|
235 829
|
250 879
|
|
| Additional Paid In Capital |
3 063
|
3 063
|
3 063
|
3 063
|
3 063
|
3 063
|
3 063
|
3 063
|
3 063
|
3 063
|
3 063
|
3 063
|
|
| Other Equity |
65 020
|
66 204
|
67 727
|
69 496
|
69 496
|
61 656
|
61 656
|
59 042
|
59 042
|
59 042
|
59 042
|
60 393
|
|
| Total Equity |
494 934
N/A
|
498 550
+1%
|
553 576
+11%
|
629 072
+14%
|
662 002
+5%
|
516 884
-22%
|
524 772
+2%
|
564 703
+8%
|
559 968
-1%
|
514 536
-8%
|
507 934
-1%
|
524 334
+3%
|
|
| Total Liabilities & Equity |
1 739 865
N/A
|
1 634 989
-6%
|
1 787 817
+9%
|
1 557 299
-13%
|
1 605 098
+3%
|
1 631 195
+2%
|
1 614 002
-1%
|
1 390 788
-14%
|
1 813 280
+30%
|
1 456 300
-20%
|
1 335 469
-8%
|
1 302 211
-2%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
21
|
|